WO2025230860 - SOLID FORMS OF MACROCYCLIC COMPOUNDS AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2025/230860
Publication Date
06.11.2025
International Application No.
PCT/US2025/026585
International Filing Date
28.04.2025
Title **
[English]
SOLID FORMS OF MACROCYCLIC COMPOUNDS AND USES THEREOF
[French]
FORMES SOLIDES DE COMPOSÉS MACROCYCLIQUES ET LEURS UTILISATIONS
Applicants **
AMGEN INC.
Inventors
BHATT, Jayshil
LOPEZ-MEJIAS, Vilmali
VISONTAI, Laszlo
LIANG, Yicong
NEWMAN, Jake
HARDIN, Taylor Cassianna
SMITH, Adam Nicholas
ALHASHIM, Rayan
FARAJ, Xavier
AGARWAL, Prashant
Priority Data
63/640,189
29.04.2024
US
63/646,460
13.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4658 | |
| EPO | Filing, Examination, Granting | 50781 | |
| Japan | Filing, Examination, Granting | 3761 | |
| South Korea | Filing, Examination, Granting | 5232 | |
| USA | Filing, Examination, Granting | 16040 |
Total:
80,472
Contact Us
Abstract[English]
The disclosure provides solid forms of Compound A, as described herein. The disclosure also provides pharmaceutical compositions comprising the disclosed solid forms and methods of using the disclosed solid forms and pharmaceutical compositions (e.g., to treat cancer).[French]
L'invention concerne des formes solides du composé A, telles que définies dans la description. L'invention concerne également des compositions pharmaceutiques comprenant les formes solides divulguées et des procédés d'utilisation des formes solides et des compositions pharmaceutiques divulguées (p. ex. pour traiter le cancer).